Universal Cells
Michaela Anderson is currently a Principal Research Associate at Universal Cells since April 2022. Prior to this role, Michaela held positions as a Research Scientist III at Seattle Children's and as a Research Scientist/Engineer at University of Washington. With a Master of Science in Clinical Microbiology from the University of Wisconsin-La Crosse, Michaela has a strong background in molecular diagnostics, research, and laboratory techniques. Michaela's experience includes extensive hands-on training in clinical microbiology through various internships and research fellowships. Michaela has consistently shown expertise in RNA/DNA extraction, PCR assays, quality control, and lab organization while adhering to industry guidelines.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.